维普中文期刊产品整合服务
34篇 您的检索式:作者名="Kneteman N"
    题名 作者 年代 出处 被引量
1Tacolimus as intervention in the treatment of hyperlipidemia after transplant 显示文摘Roy A Kneteman N Lilly L 2006Transpalntation2006,82,4:1
2Donorderived bacteremia in liver transplant recipients despite antibiotic prophylaxis显示文摘Doucette KE AI-Saif M Kneteman N 2013Am J Transplant2013,13,4:1
3The role of macrophages in xenograft rejection显示文摘Cadili A Kneteman N 2008Transplant Proc2008,40,10:1
4Combined hepatic and inferior vena cava resection for colorectal metastases 显示文摘Johnson S T Blitz M Kneteman N 2006J Gastrointest Surg2006,10,2:1
5Peak cyelos- porine levels correlated with freedom from liver graft re- jection: Results of a prospective, randomized comparison of neural and sandmen for liver transplantation显示文摘Grant D Kneteman N Tehervenkov J 2007Tans- plantation2007,67,8:1
6Comparative risk of bloodstream infection in organ transplant recipients显示文摘McClean K Kneteman N Taylor G 1994Infect Control Hosp Epidemiol1994,15,:1
7The role of macrophages in xenograft rejection显示文摘Cadili A Kneteman N 2008Transplant Proc2008,40,10:1
8Investigation of aprimary requirement of orang preservation solution显示文摘Churchill T A Kneteman N M 1998Transplantion1998,65,4:1
9Comparative risk of bloodstream infection in organ transplant recipients显示文摘McClean K Kneteman N Taylor G 1994Infect Control Hosp Epidemiol1994,15,9:1
10The role of macrophages in xenograft rejection显示文摘Cadili A Kneteman N 2008Transplant Proc2008,40,10:1
11Technical aspects of twostage orthotopic segmental intestinal transplantation in pigs:a model for living related small intestinal transplantation显示文摘Friedlich MS Yao S Kneteman N 1996Transplant Proc1996,28,5:1
12Generation of improved mouse models for the study of hepatitis C virus显示文摘Douglas D N Kneteman N M 2015Eur J Pharmacol2015,759,:1
13Hepatitis C virus replication in mice with chimeric human livers 显示文摘Mercer D F Schiller D E Elliott J F Douglas D N Hao C Rinfret A Addison W R Fischer K P Churchill T A Lakey J R Tyrrell D L Kneteman N M 2001Nat Med2001,,08:1
14Anti-HCV thera- pies in chimeric scid-Alb/uPA mice parallel outcomes in human clinical application显示文摘Kneteman N M Weiner A J O'Connell J 2006Hepatology2006,43,:1
15Tacrolimus as intervention in the treatment of hyperlipidemia after liver transplant显示文摘Roy A Kneteman N Lilly L 2006Transplantation2006,82,4:1
16Combined nepatic and inferior vena cava resection for colorectal metastases显示文摘Johnson ST Blitz M Kneteman N 2006Gastrointest Surg2006,10,2:1
17The place of down- staging for hepatocellular carcinoma 显示文摘Toso C Mentha G Kneteman N M 2010J Hepatol2010,52,6:1
18m-TOR inhibitors: what role in liver transplantation显示文摘Kawahara T Asthana S Kneteman N M 2011J Hepatol2011,55,6:1
19Sirolimus based immunosuppression is associated with in- creased survival after liver transplantation for hepatocellular carcinoma显示文摘Toso C Merani S Bigam D L Shapiro A M Kneteman N M 2010Hepatology2010,51,:1
20Siroli- mus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular car- cinoma显示文摘Kneteman N M Oberholzer J A1 Saghier M 2004Liver Transpl2004,10,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费